The occurrence of severe fatigue after Guillain-Barré syndrome (GBS), and its relation with disease course, clinical characteristics, and antecedent infections was studied in 100 GBS patients. Severe fatigue, expressed as a mean Fatigue Severity Scale (FSS) score of 5.0 or more, was present in 60% of all patients. It was more frequently present in females and in patients over 50 years (p<0.01). There was no significant relationship between fatigue severity and the level of functional disability at nadir, antecedent events or infections, clinical variables, and time to follow-up after GBS.
This is a preview of subscription content, log in to check access.
Dornonville de la Cour C, Andersen H, Stalberg E, Fuglsang_Frederiksen A, Jakobsen J (2005) Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barré syndrome. Muscle Nerve 31:70–77CrossRefGoogle Scholar
Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF (1994) Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18(Suppl 1):S79–83PubMedGoogle Scholar
Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS et al. (2004) Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP. Neurology 63:2393–2395PubMedGoogle Scholar
Hartung HP, van der Meché FG, Pollard JD (1998) Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies. Curr Opin Neurol 11497–513Google Scholar
Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14:1103–1109PubMedCrossRefGoogle Scholar
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMedGoogle Scholar
Merkies IS, Schmitz PI, Samijn JP, van der Meché FG, van Doorn PA (1999) Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53(8):1648–1654PubMedGoogle Scholar
Van Koningsveld R, Schmitz PI, Ang CW, Groen J, Osterhaus AD, van der Meché FG et al. (2002) Infections and course of disease in mild forms of Guillain-Barré syndrome. Neurology 58:610–614PubMedGoogle Scholar
Van Koningsveld R, van Doorn PA, Schmitz PI, Ang CW, van der Meché FG (2000) Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620–625PubMedGoogle Scholar